MARATTO

article · Journal of the Pakistan Medical Association

Prognostic value of basal markers (epidermal growth factor receptor “EGFR” and cytokeratin 5/6) expression in triple-negative invasive breast cancer

20233 citationsOpen accessKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Triple-negative breast cancer patients who expressed epidermal growth factor receptor and/or cytokeratin 5/6 were found to have poor findings, with worse disease-free survival and overall survival.

Research topics

  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Lung Cancer Treatments and Mutations

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.47391/jpma.egy-s4-33

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.